Beerse, Belgium

Peter Evan Owen Williams

This inventor holds 1 USPTO granted patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Viiv Healthcare Company; and. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Evan Owen Williams. Retrieved from https://idiyas.com/inventor/peter-evan-owen-williams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Evan Owen Williams and HIV Viral Remission Research

Introduction

Peter Evan Owen Williams is an inventor associated with Beerse, Belgium. His patent work concerns a method for achieving HIV viral remission using long-acting antiretroviral agents.

Latest Patents

Williams is associated with 1 patent: “Method of Achieving HIV Viral Remission Using Long-Acting Antiretroviral Agents.” The patent describes a method intended to achieve HIV viral remission in a patient in need of treatment.

Career Highlights

The listed organizations associated with Williams include ViiV Healthcare Company and the United States of America, as represented by the Secretary of the Department of Health and Human Services. His patent reflects work at the intersection of antiretroviral treatment and HIV research.

Collaborations

Williams’s listed coworker is Michele B. Daly. The organizations associated with the patent indicate collaboration between pharmaceutical and public-sector research interests.

Conclusion

Peter Evan Owen Williams’s patent focuses on using long-acting antiretroviral agents as part of a method for pursuing HIV viral remission.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…